Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P07550: Variant p.Thr164Ile

Beta-2 adrenergic receptor
Gene: ADRB2
Feedback?
Variant information Variant position: help 164 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Threonine (T) to Isoleucine (I) at position 164 (T164I, p.Thr164Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help The Gly-16 allele is overrepresented in individuals affected by nocturnal asthma as compared to controls, and appears to be an important genetic factor in the expression of this asthmatic phenotype. Additional information on the polymorphism described.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 164 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 413 The length of the canonical sequence.
Location on the sequence: help LLTKNKARVIILMVWIVSGL T SFLPIQMHWYRATHQEAINC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINC

                              LLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHQEAINC

Rhesus macaque                LLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINC

Mouse                         LLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKKAIDC

Rat                           LLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKQAIDC

Pig                           LLTKNKARVVILMVWVVSGLISFLPIKMHWYQATHREALNC

Bovine                        LLTKNKARVVILMVWIVSGLTSFLPIQMHWYRASHKEAINC

Cat                           LLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHQEAINC

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 413 Beta-2 adrenergic receptor
Transmembrane 151 – 174 Helical; Name=4
Disulfide bond 106 – 191
Helix 147 – 170



Literature citations
Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects.
Reihsaus E.; Innis M.; Macintyre N.; Liggett S.B.;
Am. J. Respir. Cell Mol. Biol. 8:334-339(1993)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ARG-16; GLN-27; MET-34 AND ILE-164;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.